# Masimo Corporation clinical trials: 106 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 106 trials with Masimo Corporation as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Masimo Corporation: 106 rows for $5.30, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/masimo-corporation

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 106
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 106, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 31, 2025 | NCT07223177 | Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations | Masimo Corporation | Not applicable | Recruiting | SpO2 | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07223177) |
| October 31, 2025 | NCT07223164 | Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease | Masimo Corporation | Not applicable | Completed | Healthy | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07223164) |
| April 10, 2025 | NCT06922461 | Clinical Performance of Masimo INVSENSOR00048 (DALI0001) | Masimo Corporation | Not applicable | Terminated | Temperature | 4 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06922461) |
| May 29, 2024 | NCT06432881 | Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE) | Masimo Corporation | Not applicable | Completed | Hypoxemia | 461 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06432881) |
| March 27, 2024 | NCT06334055 | Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073 | Masimo Corporation | Not applicable | Completed | Healthy | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06334055) |
| March 4, 2024 | NCT06289556 | Clinical Performance of Masimo INVSENSOR00048 | Masimo Corporation | Not applicable | Terminated | Fever, Healthy | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06289556) |
| January 22, 2024 | NCT06217380 | Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program | Masimo Corporation | Not applicable | Terminated | Opioid Use | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06217380) |
| November 28, 2023 | NCT06148623 | Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation | Masimo Corporation | Not applicable | Completed | Healthy | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06148623) |
| November 7, 2023 | NCT06120777 | Clinical Validation for SpO2 Function of Masimo INVSENSOR00069 | Masimo Corporation | Not applicable | Completed | Healthy | 89 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06120777) |
| October 6, 2023 | NCT06071754 | Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057 | Masimo Corporation | Not applicable | Completed | Healthy, Atrial Fibrillation | 365 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06071754) |
| August 1, 2023 | NCT05968079 | Performance Comparison Between Masimo W1™ and Apple Watch Series 8 | Masimo Corporation | Not applicable | Completed | Healthy Volunteers | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05968079) |
| July 3, 2023 | NCT05926648 | Form, Fit, and Function of INVSENSOR00061 | Masimo Corporation | Not applicable | Completed | Healthy | 53 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05926648) |
| June 29, 2023 | NCT05924945 | Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms | Masimo Corporation | Not applicable | Terminated | Opioid Use Disorder | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05924945) |
| June 9, 2023 | NCT05896267 | SpO2 Data Collection in Pediatric Patients Using INVSENSOR00061 | Masimo Corporation | Not applicable | Completed | Spo2 | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05896267) |
| May 30, 2023 | NCT05879081 | Clinical Performance of Masimo MightySat Rx in Pediatric Populations | Masimo Corporation | Not applicable | Completed | RRP (Respiration Rate From PPG) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05879081) |
| March 28, 2023 | NCT05787782 | Validation of the Masimo INVSENSOR00063 in Febrile and Afebrile Subejcts | Masimo Corporation | Not applicable | Completed | Fever | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05787782) |
| March 22, 2023 | NCT05779397 | Clinical Performance of Masimo Rad-GT | Masimo Corporation | Not applicable | Completed | Healthy | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05779397) |
| January 6, 2023 | NCT05674344 | Calibration and Validation of the Masimo Temperature Device in Febrile Patients | Masimo Corporation | Not applicable | Completed | Fever | 170 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05674344) |
| January 6, 2023 | NCT05674136 | Clinical Equivalence of Masimo INVSENSOR00061 to RD SET Neo | Masimo Corporation | Not applicable | Completed | Healthy | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05674136) |
| December 5, 2022 | NCT05636098 | Repeatability and Reproducibility of Oxygen Reserve Index (ORi) | Masimo Corporation | Not applicable | Completed | Healthy | 53 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05636098) |
| July 27, 2022 | NCT05476250 | Clinical Performance of Masimo INVSENSOR00057 for Atrial Fibrillation Detection | Masimo Corporation | Not applicable | Terminated | Healthy | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05476250) |
| July 25, 2022 | NCT05472012 | Performance of Masimo INVSENSOR00057 in Detecting Atrial Fibrillation (Afib) | Masimo Corporation | Not applicable | Completed | Atrial Fibrillation | 139 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05472012) |
| July 18, 2022 | NCT05462886 | Clinical Performance of Masimo INVSENSOR00057 for Heart Rate Measurements | Masimo Corporation | Not applicable | Completed | Healthy | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05462886) |
| April 18, 2022 | NCT05332392 | Clinical Performance of Masimo INVSENSOR00040 | Masimo Corporation | Not applicable | Completed | Healthy | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05332392) |
| October 19, 2021 | NCT05083351 | Performance of Masimo MightySat Pulse Oximeter in Differing Levels of Skin Pigmentation | Masimo Corporation | Not applicable | Completed | Healthy | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05083351) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 106 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 85 |
| Terminated | 18 |
| Withdrawn | 2 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Anemia | 8 |
| Fever | 3 |
| Hypoxia | 2 |
| Atrial Fibrillation | 2 |
| Obesity, Morbid | 1 |
| Obesity | 1 |
| Carbon Monoxide Poisoning | 1 |
| Sleep Apnea, Obstructive | 1 |
| Opioid-Related Disorders | 1 |
| Sleep Apnea Syndromes | 1 |
| Pain, Postoperative | 1 |
| Recurrent respiratory papillomatosis | 1 |
| Pressure Ulcer | 1 |
| Wounds and Injuries | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Postoperative Hemorrhage | 1 |
| Transfusion Reaction | 1 |
| Hypovolemia | 1 |
| Hypertension | 1 |
| Hypotension | 1 |
| Hyperoxia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Office supply stores in the United States](https://specstream.ai/data/businesses/office-supply-stores/united-states)
- [Obstetrics and gynecology practices in the United States](https://specstream.ai/data/businesses/obstetrics-and-gynecology-practices/united-states)
- [Neuropathology practices in the United States](https://specstream.ai/data/businesses/neuropathology-practices/united-states)
- [Natural gas utilities in the United States](https://specstream.ai/data/businesses/natural-gas-utilities/united-states)
- [Mortgage lenders in the United States](https://specstream.ai/data/businesses/mortgage-lenders/united-states)
- [Mobility equipment companies in the United States](https://specstream.ai/data/businesses/mobility-equipment-companies/united-states)
